This article seeks to address different aspects related to Firocoxib, with the aim of providing the reader with a holistic view of this topic. Along these lines, the importance of Firocoxib in various spheres will be analyzed, as well as its implications in today's society. Different perspectives and approaches will be explored to fully understand the relevance of Firocoxib, as well as its impact on the contemporary world. Through this article, the aim is to provide a complete overview that allows the reader to reflect and form an informed opinion about Firocoxib.
| Clinical data | |
|---|---|
| Trade names | Equioxx, Previcox |
| AHFS/Drugs.com | |
| License data | |
| Routes of administration | By mouth |
| ATCvet code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H20O5S |
| Molar mass | 336.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Firocoxib, sold under the brand names Equioxx and Previcox among others, is a nonsteroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, approved for use in horses (Equioxx) and for use in dogs (Previcox).[2][4][9] Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses.[10] Firocoxib is not intended or approved for use in human medicine.[2][4][5][6][11]
Firocoxib, manufactured by Merial, was approved for veterinary use in the United States for dogs in July 2004,[12] and for horses in July 2007, as an oral paste (Equioxx) and July 2016, as tablets.[13][14]
Firocoxib is also available as a generic medication for horses[14] and for dogs.[12]